EPRX Eupraxia Pharmaceuticals Inc. - Common Stock
$6.93
Price · Aug 19, 2026
52W Range
$5–$9
46% of range
Analyst Rating
BUY
11 analysts
Price Target
$16
+136% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
EPRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.92
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$5 – $9
EPRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
EPRX
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
EPRX
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
EPRX
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
EPRX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
EPRX
Peer Median
EPRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 4 36.4%
- Buy 6 54.5%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
10 analysts · 2026-08-15
Median
$15.75
← Below all targets
$6.92
Low
$11.00
High
$25.00
Median target
$15.75
+127.4%
Mean target
$16.35
+136.1%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.07%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.23 | $-0.23 | -0.00% |
| Dec. 31, 2025 | $-0.37 | $-0.17 | -0.20% |
| Sept. 30, 2025 | $-0.19 | $-0.16 | -0.03% |
| June 30, 2025 | $-0.26 | $-0.19 | -0.07% |
| March 31, 2025 | $-0.21 | $-0.17 | -0.04% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| EPRX | — | — | — | — | — | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 66 filers · $123.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 18 (-2 vs prior Q) | 4 (+1 vs prior Q) | 20 (+1 vs prior Q) | 17 (+11 vs prior Q) | +2.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Affinity Asset Advisors, LLC | $10,906,500 | 1,650,000 | 8.81% | Shares |
| Balyasny Asset Management L.P. | $8,923,599 | 1,350,015 | 7.21% | Shares |
| Vivo Capital, LLC | $8,923,500 | 1,350,000 | 7.21% | Shares |
| SCOTIA CAPITAL INC. | $8,782,272 | 1,343,726 | 7.10% | Shares |
| PFM Health Sciences, LP | $8,002,469 | 1,210,661 | 6.47% | Shares |
| GREAT POINT PARTNERS LLC | $7,932,000 | 1,200,000 | 6.41% | Shares |
| Rubric Capital Management LP | $5,733,673 | 867,424 | 4.63% | Shares |
| Ikarian Capital, LLC | $5,352,388 | 809,741 | 4.32% | Shares |
| Woodline Partners LP | $4,936,771 | 746,864 | 3.99% | Shares |
| Point72 Asset Management, L.P. | $4,827,716 | 730,284 | 3.90% | Shares |
| AMERIPRISE FINANCIAL INC | $4,699,869 | 711,024 | 3.80% | Shares |
| Redmile Group, LLC | $4,041,354 | 611,400 | 3.27% | Shares |
| MILLENNIUM MANAGEMENT LLC | $2,918,796 | 441,586 | 2.36% | Shares |
| CITADEL ADVISORS LLC | $2,674,452 | 404,607 | 2.16% | Shares |
| Alyeska Investment Group, L.P. | $2,478,750 | 375,000 | 2.00% | Shares |
| PICTON MAHONEY ASSET MANAGEMENT | $2,385,404 | 360,878 | 1.93% | Shares |
| Velan Capital Investment Management LP | $2,326,720 | 352,000 | 1.88% | Shares |
| Seven Fleet Capital Management LP | $2,212,929 | 334,785 | 1.79% | Shares |
| Aisling Capital Management LP | $2,148,250 | 325,000 | 1.74% | Shares |
| SummitTX Capital, L.P. | $2,107,162 | 318,784 | 1.70% | Shares |
| ROYAL BANK OF CANADA | $2,045,000 | 309,400 | 1.65% | Shares |
| DV EQUITIES, LLC | $1,824,360 | 276,000 | 1.47% | Shares |
| ORBIMED ADVISORS LLC | $1,778,090 | 269,000 | 1.44% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,749,806 | 264,721 | 1.41% | Shares |
| Ally Bridge Group (NY) LLC | $1,666,877 | 252,175 | 1.35% | Shares |
| CIBC WORLD MARKET INC. | $1,539,137 | 234,673 | 1.24% | Shares |
| DAFNA Capital Management LLC | $1,491,216 | 225,600 | 1.20% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,461,365 | 221,084 | 1.18% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,405,636 | 212,653 | 1.14% | Shares |
| JANE STREET GROUP, LLC | $1,208,037 | 184,203 | 0.98% | Shares |
| TD Waterhouse Canada Inc. | $534,915 | 79,607 | 0.43% | Shares |
| XTX Topco Ltd | $464,452 | 70,265 | 0.38% | Shares |
| Annis Gardner Whiting Capital Advisors, LLC | $396,600 | 60,000 | 0.32% | Shares |
| GOLDMAN SACHS GROUP INC | $383,763 | 58,058 | 0.31% | Shares |
| 1832 Asset Management L.P. | $333,356 | 50,432 | 0.27% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $305,018 | 46,145 | 0.25% | Shares |
| Stonepine Capital Management, LLC | $287,476 | 43,491 | 0.23% | Shares |
| BANK OF MONTREAL /CAN/ | $252,195 | 38,457 | 0.20% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $239,354 | 36,211 | 0.19% | Shares |
| UBS Group AG | $234,648 | 35,499 | 0.19% | Shares |
| Brevan Howard Capital Management LP | $229,810 | 34,767 | 0.19% | Shares |
| Qube Research & Technologies Ltd | $226,307 | 34,237 | 0.18% | Shares |
| MARSHALL WACE, LLP | $151,904 | 22,981 | 0.12% | Shares |
| AXQ CAPITAL, LP | $139,802 | 21,150 | 0.11% | Shares |
| Jump Financial, LLC | $130,878 | 19,800 | 0.11% | Shares |
| NATIXIS | $115,215 | 17,644 | 0.09% | Shares |
| JPMORGAN CHASE & CO | $93,486 | 14,186 | 0.08% | Shares |
| China Universal Asset Management Co., Ltd. | $82,625 | 12,500 | 0.07% | Shares |
| RAYMOND JAMES FINANCIAL INC | $80,774 | 12,220 | 0.07% | Shares |
| TCI Wealth Advisors, Inc. | $72,710 | 11,000 | 0.06% | Shares |
| GUARDIAN WEALTH ADVISORS, LLC / NC | $69,405 | 10,500 | 0.06% | Shares |
| Aptus Capital Advisors, LLC | $69,405 | 10,500 | 0.06% | Shares |
| Lynx1 Capital Management LP | $66,100 | 10,000 | 0.05% | Shares |
| Shay Capital LLC | $66,100 | 10,000 | 0.05% | Shares |
| Integrated Wealth Concepts LLC | $65,274 | 9,875 | 0.05% | Shares |
| Federation des caisses Desjardins du Quebec | $59,394 | 9,091 | 0.05% | Shares |
| Northwest & Ethical Investments L.P. | $41,050 | 6,237 | 0.03% | Shares |
| BlackRock, Inc. | $33,308 | 5,039 | 0.03% | Shares |
| Persistent Asset Partners Ltd | $25,059 | 3,791 | 0.02% | Shares |
| Beutel, Goodman & Co Ltd. | $23,806 | 3,627,864 | 0.02% | Shares |
| MORGAN STANLEY | $14,542 | 2,200 | 0.01% | Shares |
| TORONTO DOMINION BANK | $787 | 120 | 0.00% | Shares |
| INGALLS & SNYDER LLC | $452 | 68,450 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $344 | 52 | 0.00% | Shares |
| Quarry LP | $324 | 49 | 0.00% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $36 | 8 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Joseph S. Freedman ×2 filings | March 16, 2026 | 9.00% | Amendment | — | SEC |
| Joseph S. Freedman (2) | Nov. 7, 2024 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.